Ganglioside (GM1)-treated T cells shed CD4

William J. Morrison, Halina Offner, Arthur Vandenbark

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

In previous studies (Morrison et al., 1990), we showed that ganglioside (GM1) modulation of CD4 was associated with activation of phospholipase C and increased production of inositol triphosphate, but not with activation of protein kinase C. These results demonstrated a unique signal transduction pathway related to GM1 modulation of CD4 on T cells and raised the question as to whether intracellular Ca2+ levels and related protein kinases would be affected by GM1-induced signalling. We now show that GM1 modulation of CD4 from human T cells corresponds to decreased cellular Ca2+ without significant changes in cellular photein phosphorylation. In the course of this study we discovered that T cells challenged with GM1 exhibited new proteins in their surrounding media. Fractionation of cellular and supernatant proteins show that cells treated with GM1 released proteins with an approximate molecular weight (Mr) of 49 000. This was exclusive of GM1 protein association and GM1-induced protein phosphorylation. Immunoblots demonstrated the presence of CD4 in GM1-treated cell supernatants. Western immunoblots using anti-CD4 antibodies detected a lower Mr form (49 000) of CD4 in the supernatants of GM1-treated cells. These studies further define the unique nature of GM1 signalling relating to modulation of CD4 and demonstrate that the fate of GM1 modulated CD4, in part, involves protein shedding.

Original languageEnglish (US)
Pages (from-to)77-84
Number of pages8
JournalImmunopharmacology
Volume22
Issue number2
DOIs
StatePublished - 1991

Fingerprint

G(M1) Ganglioside
T-Lymphocytes
Proteins
Phosphorylation
Type C Phospholipases
Inositol
Protein Kinases
Protein Kinase C
Anti-Idiotypic Antibodies
Signal Transduction
Molecular Weight
Western Blotting

Keywords

  • Calcium
  • Ganglioside
  • T-helper cell

ASJC Scopus subject areas

  • Pharmacology

Cite this

Ganglioside (GM1)-treated T cells shed CD4. / Morrison, William J.; Offner, Halina; Vandenbark, Arthur.

In: Immunopharmacology, Vol. 22, No. 2, 1991, p. 77-84.

Research output: Contribution to journalArticle

@article{68d48410f10242c48757ddcfd35660b3,
title = "Ganglioside (GM1)-treated T cells shed CD4",
abstract = "In previous studies (Morrison et al., 1990), we showed that ganglioside (GM1) modulation of CD4 was associated with activation of phospholipase C and increased production of inositol triphosphate, but not with activation of protein kinase C. These results demonstrated a unique signal transduction pathway related to GM1 modulation of CD4 on T cells and raised the question as to whether intracellular Ca2+ levels and related protein kinases would be affected by GM1-induced signalling. We now show that GM1 modulation of CD4 from human T cells corresponds to decreased cellular Ca2+ without significant changes in cellular photein phosphorylation. In the course of this study we discovered that T cells challenged with GM1 exhibited new proteins in their surrounding media. Fractionation of cellular and supernatant proteins show that cells treated with GM1 released proteins with an approximate molecular weight (Mr) of 49 000. This was exclusive of GM1 protein association and GM1-induced protein phosphorylation. Immunoblots demonstrated the presence of CD4 in GM1-treated cell supernatants. Western immunoblots using anti-CD4 antibodies detected a lower Mr form (49 000) of CD4 in the supernatants of GM1-treated cells. These studies further define the unique nature of GM1 signalling relating to modulation of CD4 and demonstrate that the fate of GM1 modulated CD4, in part, involves protein shedding.",
keywords = "Calcium, Ganglioside, T-helper cell",
author = "Morrison, {William J.} and Halina Offner and Arthur Vandenbark",
year = "1991",
doi = "10.1016/0162-3109(91)90032-T",
language = "English (US)",
volume = "22",
pages = "77--84",
journal = "Immunopharmacology",
issn = "0162-3109",
publisher = "Elsevier BV",
number = "2",

}

TY - JOUR

T1 - Ganglioside (GM1)-treated T cells shed CD4

AU - Morrison, William J.

AU - Offner, Halina

AU - Vandenbark, Arthur

PY - 1991

Y1 - 1991

N2 - In previous studies (Morrison et al., 1990), we showed that ganglioside (GM1) modulation of CD4 was associated with activation of phospholipase C and increased production of inositol triphosphate, but not with activation of protein kinase C. These results demonstrated a unique signal transduction pathway related to GM1 modulation of CD4 on T cells and raised the question as to whether intracellular Ca2+ levels and related protein kinases would be affected by GM1-induced signalling. We now show that GM1 modulation of CD4 from human T cells corresponds to decreased cellular Ca2+ without significant changes in cellular photein phosphorylation. In the course of this study we discovered that T cells challenged with GM1 exhibited new proteins in their surrounding media. Fractionation of cellular and supernatant proteins show that cells treated with GM1 released proteins with an approximate molecular weight (Mr) of 49 000. This was exclusive of GM1 protein association and GM1-induced protein phosphorylation. Immunoblots demonstrated the presence of CD4 in GM1-treated cell supernatants. Western immunoblots using anti-CD4 antibodies detected a lower Mr form (49 000) of CD4 in the supernatants of GM1-treated cells. These studies further define the unique nature of GM1 signalling relating to modulation of CD4 and demonstrate that the fate of GM1 modulated CD4, in part, involves protein shedding.

AB - In previous studies (Morrison et al., 1990), we showed that ganglioside (GM1) modulation of CD4 was associated with activation of phospholipase C and increased production of inositol triphosphate, but not with activation of protein kinase C. These results demonstrated a unique signal transduction pathway related to GM1 modulation of CD4 on T cells and raised the question as to whether intracellular Ca2+ levels and related protein kinases would be affected by GM1-induced signalling. We now show that GM1 modulation of CD4 from human T cells corresponds to decreased cellular Ca2+ without significant changes in cellular photein phosphorylation. In the course of this study we discovered that T cells challenged with GM1 exhibited new proteins in their surrounding media. Fractionation of cellular and supernatant proteins show that cells treated with GM1 released proteins with an approximate molecular weight (Mr) of 49 000. This was exclusive of GM1 protein association and GM1-induced protein phosphorylation. Immunoblots demonstrated the presence of CD4 in GM1-treated cell supernatants. Western immunoblots using anti-CD4 antibodies detected a lower Mr form (49 000) of CD4 in the supernatants of GM1-treated cells. These studies further define the unique nature of GM1 signalling relating to modulation of CD4 and demonstrate that the fate of GM1 modulated CD4, in part, involves protein shedding.

KW - Calcium

KW - Ganglioside

KW - T-helper cell

UR - http://www.scopus.com/inward/record.url?scp=0025918167&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025918167&partnerID=8YFLogxK

U2 - 10.1016/0162-3109(91)90032-T

DO - 10.1016/0162-3109(91)90032-T

M3 - Article

VL - 22

SP - 77

EP - 84

JO - Immunopharmacology

JF - Immunopharmacology

SN - 0162-3109

IS - 2

ER -